Røe OD[au] - Search Results

Year	Number of Results
1989	1
2007	1
2008	1
2009	1
2010	2
2011	2
2012	8
2013	11
2014	10
2015	4
2016	6
2017	3
2018	7
2019	7
2020	4
2021	5
2022	7
2023	3

1

The established and future biomarkers of malignant pleural mesothelioma.

Panou V, Vyberg M, Weinreich UM, Meristoudis C, Falkmer UG, Røe OD. Panou V, et al. Among authors: roe od. Cancer Treat Rev. 2015 Jun;41(6):486-95. doi: 10.1016/j.ctrv.2015.05.001. Epub 2015 May 8. Cancer Treat Rev. 2015. PMID: 25979846 Review.

2

Inherited Genetic Mutations and Polymorphisms in Malignant Mesothelioma: A Comprehensive Review.

Panou V, Røe OD. Panou V, et al. Among authors: roe od. Int J Mol Sci. 2020 Jun 17;21(12):4327. doi: 10.3390/ijms21124327. Int J Mol Sci. 2020. PMID: 32560575 Free PMC article. Review.

3

Mesothelioma diagnosis and prognosis, are we moving beyond histology and performance status towards circulating biomarkers?

Røe OD. Røe OD. J Thorac Dis. 2018 Jun;10(Suppl 17):S1956-S1961. doi: 10.21037/jtd.2018.06.12. J Thorac Dis. 2018. PMID: 30023090 Free PMC article. No abstract available.

4

Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic.

Røe OD, Stella GM. Røe OD, et al. Eur Respir Rev. 2015 Mar;24(135):115-31. doi: 10.1183/09059180.00007014. Eur Respir Rev. 2015. PMID: 25726562 Free PMC article. Review.

5

Response to "Revisiting 'BAP1ness' in Malignant Pleural Mesothelioma".

Røe OD, Creaney J; BAP1 Study Group. Røe OD, et al. J Thorac Oncol. 2022 Aug;17(8):e69-e70. doi: 10.1016/j.jtho.2022.05.013. J Thorac Oncol. 2022. PMID: 35931425 Free article. No abstract available.

6

Prognostic role of microscopically positive margins for primary gastrointestinal stromal tumors: a systematic review and meta-analysis.

Zhi X, Jiang B, Yu J, Røe OD, Qin J, Ni Q, Sun L, Xu M, Zhu J, Ma L. Zhi X, et al. Among authors: roe od. Sci Rep. 2016 Feb 19;6:21541. doi: 10.1038/srep21541. Sci Rep. 2016. PMID: 26891953 Free PMC article. Review.

7

Democratic and ethical problem of lung cancer screening: exclusion of true high-risk populations. Can it be fixed? Yes.

Røe OD. Røe OD. BMJ Open Respir Res. 2020 Dec;7(1):e000811. doi: 10.1136/bmjresp-2020-000811. BMJ Open Respir Res. 2020. PMID: 33323364 Free PMC article. Review.

8

Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art.

Szejniuk WM, Robles AI, McCulloch T, Falkmer UGI, Røe OD. Szejniuk WM, et al. Among authors: roe od. Pharmacogenomics J. 2019 Feb;19(1):5-14. doi: 10.1038/s41397-018-0029-1. Epub 2018 Sep 7. Pharmacogenomics J. 2019. PMID: 30190521 Review.

9

Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review.

Chen X, Liu Y, Røe OD, Qian Y, Guo R, Zhu L, Yin Y, Shu Y. Chen X, et al. Among authors: roe od. PLoS One. 2013;8(3):e59314. doi: 10.1371/journal.pone.0059314. Epub 2013 Mar 21. PLoS One. 2013. PMID: 23555654 Free PMC article. Review.

10

Diagnostic capacity of BAP1 and MTAP in cytology from effusions and biopsy in mesothelioma.

Lynggård LA, Panou V, Szejniuk W, Røe OD, Meristoudis C. Lynggård LA, et al. Among authors: roe od. J Am Soc Cytopathol. 2022 Nov-Dec;11(6):385-393. doi: 10.1016/j.jasc.2022.07.003. Epub 2022 Jul 9. J Am Soc Cytopathol. 2022. PMID: 35945149 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

74 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year